tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

ZYME Stock Latest News

Zymeworks Unveils Promising Data on Novel Cancer Therapies at AACR 2025
Company AnnouncementsZymeworks Unveils Promising Data on Novel Cancer Therapies at AACR 2025
12d ago
ZYME
Zymeworks Strengthens Clinical Leadership with New Senior VP Appointment
PremiumCompany Announcements
Zymeworks Strengthens Clinical Leadership with New Senior VP Appointment
16d ago
ZYME
Zymeworks to Announce Q1 2025 Financial Results and Host Conference Call
PremiumCompany Announcements
Zymeworks to Announce Q1 2025 Financial Results and Host Conference Call
20d ago
ZYME
Kalaris Therapeutics appoints Leone Patterson to board of directors
PremiumThe Fly
Kalaris Therapeutics appoints Leone Patterson to board of directors
1M ago
KLRS
ZYME
Zymeworks to Engage Investors at Upcoming Conferences
PremiumCompany Announcements
Zymeworks to Engage Investors at Upcoming Conferences
1M ago
ZYME
Zymeworks to Present Promising Cancer Therapy Data at AACR Meeting
PremiumCompany AnnouncementsZymeworks to Present Promising Cancer Therapy Data at AACR Meeting
1M ago
ZYME
Zymeworks’ Promising Market Position and Strategic Focus Justify Buy Rating
Premium
Ratings
Zymeworks’ Promising Market Position and Strategic Focus Justify Buy Rating
2M ago
ZYME
Zymeworks (ZYME) Shares Surge Amid Positive Analyst Forecasts
Premium
Market News
Zymeworks (ZYME) Shares Surge Amid Positive Analyst Forecasts
2M ago
ZYME
Zymeworks initiated with an Outperform at LifeSci Capital
PremiumThe Fly
Zymeworks initiated with an Outperform at LifeSci Capital
2M ago
ZYME
Zymeworks: Hold Rating Amid Financial Challenges and Upcoming Catalysts
PremiumRatings
Zymeworks: Hold Rating Amid Financial Challenges and Upcoming Catalysts
2M ago
ZYME
Zymeworks price target raised to $13 from $12 at H.C. Wainwright
PremiumThe Fly
Zymeworks price target raised to $13 from $12 at H.C. Wainwright
2M ago
ZYME
Zymeworks price target raised to $19 from $18 at Citi
PremiumThe Fly
Zymeworks price target raised to $19 from $18 at Citi
2M ago
ZYME
Zymeworks: Promising Pipeline and Financial Stability Justify Buy Rating
PremiumRatingsZymeworks: Promising Pipeline and Financial Stability Justify Buy Rating
2M ago
ZYME
Zymeworks Faces Challenges in Diagnostic Test Development Amidst Regulatory Changes
Premium
Company Announcements
Zymeworks Faces Challenges in Diagnostic Test Development Amidst Regulatory Changes
2M ago
ZYME
Zymeworks’ Earnings Call: Achievements and Challenges
Premium
Company Announcements
Zymeworks’ Earnings Call: Achievements and Challenges
2M ago
ZYME
Zymeworks: Hold Rating Amid Limited Near-Term Catalysts and Strategic Resource Allocation
PremiumRatings
Zymeworks: Hold Rating Amid Limited Near-Term Catalysts and Strategic Resource Allocation
2M ago
ZYME
Zymeworks Reports 2024 Financial Results and Pipeline Progress
PremiumCompany Announcements
Zymeworks Reports 2024 Financial Results and Pipeline Progress
2M ago
ZYME
Zymeworks Achieves FDA Approval for Ziihera®
PremiumCompany Announcements
Zymeworks Achieves FDA Approval for Ziihera®
2M ago
8K
ZYME
Zymeworks reports Q 4EPS (31c), consensus (9c)
PremiumThe Fly
Zymeworks reports Q 4EPS (31c), consensus (9c)
2M ago
ZYME
Is ZYME a Buy, Before Earnings?
PremiumPre-EarningsIs ZYME a Buy, Before Earnings?
2M ago
ZYME
Zymeworks Secures $14 Million Milestone from GSK Collaboration
Premium
Company Announcements
Zymeworks Secures $14 Million Milestone from GSK Collaboration
2M ago
ZYME
Zymeworks achieves $14M milestone from GSK
Premium
The Fly
Zymeworks achieves $14M milestone from GSK
2M ago
GSK
ZYME

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >